Nu-Med Plus NUMD
OTC NUMD
$0.01 +0.00 (+13.33%)
As of: Nov 13, 2026 · 10:10 AM EST

Nu-Med Plus (NUMD) Return on Equity [ROE] (2014 - 2021)

Updated

Nu-Med Plus' Return on Equity [ROE] came in at -495.05% for FY2021, up 3635.68 percentage points from -4130.73% in FY2020.

Analysis

Nu-Med Plus (NUMD) Return on Equity [ROE] (2014 - 2021) Analysis & Trends

  • Return on Equity [ROE] carries a three-year change of +1474.26 percentage points (FY2018 to FY2021).
  • Per Business Quant, earlier years put Return on Equity [ROE] at -4130.73% in FY2020 and -1969.31% in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn 13.20%
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn 9.09%
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn 8.15%
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn 17.28%
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn 17.46%
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn -4.01%
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn 13.69%
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn 9.36%
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn 4.56%
10 Nu-Med Plus 835,484.67 823,182.67 - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -1,633.93%
Mar 31, 2021 -671.79%
Dec 31, 2020 -582.84%
Sep 30, 2020 -544.96%
Jun 30, 2020 -6,426.83%
Dec 31, 2018 -946.30%
Sep 30, 2018 -1,133.44%
Mar 31, 2018 -2,199.94%
Dec 31, 2017 -790.76%
Sep 30, 2016 -477.89%
Jun 30, 2016 -409.42%
Sep 30, 2014 -490.49%
Jun 30, 2014 -137.81%
Mar 31, 2014 -335.71%
API Access

Nu-Med Plus Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NUMD&period=max&api_key=YOUR_API_KEY